Atlas Trials

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

Clinical trial NCT03453528 · COMPLETED

Trial details

NCT number
NCT03453528
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate-specific Membrane AntigenmCRPC or Advanced/Metastatic Solid Tumors
Start date
2017-07-04
Primary completion
2024-12-04
Enrollment
1225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.